person · Reporting owner
LAVIZZO-MOUREY RISA J
Disclosed activity across 6 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Better Therapeutics, Inc.BTTX · Entity 94385 | Director | December 18, 2023 | December 20, 2023 |
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | Director | May 28, 2025 | May 30, 2025 |
| GENERAL ELECTRIC COGE · Entity 2813 | Director | January 03, 2023 | January 05, 2023 |
| HESS CORPHES · Entity 11019 | Director | March 06, 2020 | March 10, 2020 |
| INTEL CORPINTC · Entity 2799 | Director | May 08, 2024 | May 10, 2024 |
| Merck & Co., Inc.MRK · Entity 2807 | Director | May 29, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Better Therapeutics, Inc.
Report date December 18, 2023 · Filed December 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,750 |
Reported balance
After 2023-12-18 transaction · row 1
1 source rowRow 1 · 2023-12-18 · Grant · Acquired 3,750 · Balance 13,750 F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
GE HealthCare Technologies Inc.
Report date May 28, 2025 · Filed May 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 10,157 |
Reported balance
After 2025-05-28 transaction · row 1
1 source rowRow 1 · 2025-05-28 · Grant · Acquired 3,092 · Balance 10,157 F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
GENERAL ELECTRIC CO
Report date January 03, 2023 · Filed January 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Fee Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,252 |
Reported balance
After 2023-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-03 · Grant · Acquired 519 · Balance 13,252 F1: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan. F2: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock. F3: Payable beginning one year after termination of service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan.
F2: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock.
F3: Payable beginning one year after termination of service as a director.
HESS CORP
Report date March 06, 2020 · Filed March 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1.00 par valueSEC Table I · non-derivative | Direct | 44,379 |
Reported balance
After 2020-03-06 transaction · row 1
1 source rowRow 1 · 2020-03-06 · Grant · Acquired 1,491 · Balance 44,379 |
INTEL CORP
Report date May 08, 2024 · Filed May 10, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,403 |
Reported balance
After 2024-05-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-05-08 · Grant · Acquired 7,403 · Balance 7,403 F1: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F2: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors. F3: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.
F2: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors.
F3: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting.
Merck & Co., Inc.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 17,749.3517 |
Reported balance
After 2026-05-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-29 · Grant · Acquired 1,853.0997 · Balance 17,749.3517 F1: 1-for-1 F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3: Holdings include shares acquired in dividend reinvestment transactions. |
| Common StockSEC Table I · non-derivative | Direct | 1,000 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3: Holdings include shares acquired in dividend reinvestment transactions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2026 Filed Jun 2, 2026 18:09 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,853.0997 | $118.72 | $220,000.00 |
DisclosureSEC source: 0000310158-26-000153 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,749.3517 Underlying: Common Stock · 1,853.0997 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 17:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,863.0921 | $76.84 | $220,000.00 |
DisclosureSEC source: 0001127602-25-016354 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,367.349 Underlying: Common Stock · 2,863.0921 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 28, 2025 Filed May 30, 2025 22:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028703 · wk-form4_1748642692.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,157 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 18:15 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,752.4295 | $125.54 | $220,000.00 |
DisclosureSEC source: 0001127602-24-017571 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,120.4279 Underlying: Common Stock · 1,752.4295 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:32 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024965 · wk-form4_1716496324.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,065 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:18 UTC | INTEL CORP INTC · Entity 2799 | GrantRestricted Stock Units · Derivative | 7,403 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014994 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,403 Underlying: Common Stock · 7,403 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F2 · derivative.exercise_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors. F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting. F2 · derivative.expiration_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors. F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting. Read SEC document |
| May 07, 2024 Filed May 9, 2024 20:16 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionRestricted Stock Units · Derivative | 7,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014789 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting. F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting. Read SEC document |
| May 07, 2024 Filed May 9, 2024 20:16 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionCommon Stock | 7,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014789 · form4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 22:23 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-071960 · ownership.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,750 F1 · shares: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 22:55 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0000950170-23-027335 · ownership.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:20 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,980.7329 | $111.07 | $220,000.00 |
DisclosureSEC source: 0001127602-23-017227 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,100.3274 Underlying: Common Stock · 1,980.7329 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:29 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019777 · wf-form4_168504654928723.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,625 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 11, 2023 Filed May 15, 2023 23:11 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionRestricted Stock Units · Derivative | 4,828 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-015630 · form4.xml · derivative · entry 3 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,828 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting. F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting. Read SEC document |
| May 11, 2023 Filed May 15, 2023 23:11 UTC | INTEL CORP INTC · Entity 2799 | GrantRestricted Stock Units · Derivative | 7,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-015630 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,152 Underlying: Common Stock · 7,152 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting. F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting. Read SEC document |
| May 11, 2023 Filed May 15, 2023 23:11 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionCommon Stock | 4,828 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-015630 · form4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantDeferred Fee Phantom Stock Units · Derivative | 4,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001119 · doc4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,417 Underlying: Common stock, par value $0.01 per share · 4,417 shares Expires not disclosed F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F3 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F3 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F3 · balance_after: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon stock, par value $0.01 per share | 1,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001119 · doc4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,041 F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F1 · balance_after: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 22:10 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 519 | $82.41 | $42,770.79 |
DisclosureSEC source: 0000040545-23-000008 · wf-form4_167295660735163.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,252 Underlying: Common Stock · 519 shares Expires not disclosed F1 · security: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 21:06 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 627 | $68.21 | $42,767.67 |
DisclosureSEC source: 0001062993-22-020363 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,720 Underlying: Common Stock · 627 shares Expires not disclosed F1 · security: Acquired at a price of $68.21 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:06 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 615 | $69.53 | $42,760.95 |
DisclosureSEC source: 0001062993-22-016087 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,080 Underlying: Common Stock · 615 shares Expires not disclosed F1 · security: Acquired at a price of $69.53 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 20:40 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0000899243-22-021936 · doc4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 9, 2022. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:17 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,363.5582 | $93.08 | $220,000.00 |
DisclosureSEC source: 0001127602-22-016158 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,892.9615 Underlying: Common Stock · 2,363.5582 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 12, 2022 Filed May 16, 2022 23:28 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionRestricted Stock Units · Derivative | 3,720 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-014677 · form4.xml · derivative · entry 3 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting. F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting. Read SEC document |
| May 12, 2022 Filed May 16, 2022 23:28 UTC | INTEL CORP INTC · Entity 2799 | GrantRestricted Stock Units · Derivative | 4,828 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-014677 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,828 Underlying: Common Stock · 4,828 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting. F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting. Read SEC document |
| May 12, 2022 Filed May 16, 2022 23:28 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionCommon Stock | 3,720 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-014677 · form4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:04 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 462 | $92.62 | $42,790.44 |
DisclosureSEC source: 0001062993-22-009491 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,455 Underlying: Common Stock · 462 shares Expires not disclosed F1 · security: Acquired at a price of $92.62 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| January 30, 2022 Filed Feb 2, 2022 00:16 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionRestricted Stock Units · Derivative | 1,993 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-002837 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,993 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable). F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable). Read SEC document |
| January 30, 2022 Filed Feb 2, 2022 00:16 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionCommon Stock | 1,993 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-002837 · form4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:44 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 454 | $94.23 | $42,780.42 |
DisclosureSEC source: 0001062993-22-000345 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,984 Underlying: Common Stock · 454 shares Expires not disclosed F1 · security: Acquired at a price of $94.23 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 23:20 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | PurchaseCommon Stock | 10,000 | $4.60 | $46,000.00 |
DisclosureSEC source: 0000899243-21-049671 · doc4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| October 28, 2021 Filed Nov 2, 2021 00:55 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantStock Option (Right to Buy) · Derivative | 28,300 | $0.00 Strike: $10.97 | $0.00 |
DisclosureSEC source: 0000899243-21-042249 · doc4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,300 Underlying: Common Stock · 28,300 shares Expires 2031-10-27 F1 · derivative.exercise_date: Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021. Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 20:07 UTC | INTEL CORP INTC · Entity 2799 | PurchaseCommon Stock | 5,000 | $49.50 | $247,500.00 |
DisclosureSEC source: 0001127602-21-027641 · form4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,079 Read SEC document |
| October 01, 2021 Filed Oct 1, 2021 20:50 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 416 | $102.67 | $42,710.72 |
DisclosureSEC source: 0001062993-21-009080 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,523 Underlying: Common Stock · 416 shares Expires not disclosed F1 · security: Acquired at a price of $102.67 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. F4 · balance_after: Reflects adjustments made in connection with the 1-for-8 reverse stock split of the Issuer's common stock. Read SEC document |
| July 01, 2021 Filed Jul 1, 2021 20:49 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 3,190 | $13.40 | $42,746.00 |
DisclosureSEC source: 0001062993-21-006167 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,792 Underlying: Common Stock · 3,190 shares Expires not disclosed F1 · security: Acquired at a price of $13.40 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 17:50 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,635.3933 | $75.89 | $200,000.00 |
DisclosureSEC source: 0001127602-21-018656 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,192.6703 Underlying: Common Stock · 2,635.3933 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:45 UTC | INTEL CORP INTC · Entity 2799 | GrantRestricted Stock Units · Derivative | 3,720 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-017050 · form4.xml · derivative · entry 3 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,720 Underlying: Common Stock · 3,720 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting. F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:45 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionRestricted Stock Units · Derivative | 3,721 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-017050 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting. F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:45 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionCommon Stock | 3,721 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-017050 · form4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 00:06 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 3,244 | $13.18 | $42,755.92 |
DisclosureSEC source: 0001231205-21-000120 · edgar.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,547 Underlying: Common Stock · 3,244 shares Expires not disclosed F1 · security: Acquired at a price of $13.18 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:58 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionRestricted Stock Units · Derivative | 593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-003591 · form4.xml · derivative · entry 5 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of January 30, 2018, unless that date falls on a non-business date, in which case the next business date shall apply. F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of January 30, 2018, unless that date falls on a non-business date, in which case the next business date shall apply. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:58 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionRestricted Stock Units · Derivative | 1,580 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-003591 · form4.xml · derivative · entry 4 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,580 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable). F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable). Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:58 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionCommon Stock | 593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-003591 · form4.xml · nonDerivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:58 UTC | INTEL CORP INTC · Entity 2799 | Exercise / conversionCommon Stock | 1,580 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-003591 · form4.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. Read SEC document |
| January 30, 2021 Filed Feb 3, 2021 01:58 UTC | INTEL CORP INTC · Entity 2799 | GrantRestricted Stock Units · Derivative | 1,993 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-003591 · form4.xml · derivative · entry 3 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,993 Underlying: Common Stock · 1,993 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable). F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable). Read SEC document |
| January 04, 2021 Filed Jan 4, 2021 23:14 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 4,210 | $10.87 | $45,762.70 |
DisclosureSEC source: 0001231205-21-000019 · edgar.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,239 Underlying: Common Stock · 4,210 shares Expires not disclosed F1 · security: Acquired at a price of $10.87 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 23:48 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 7,274 | $6.29 | $45,753.46 |
DisclosureSEC source: 0001231205-20-000184 · edgar.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,944 Underlying: Common Stock · 7,274 shares Expires not disclosed F1 · security: Acquired at a price of $6.29 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 13:04 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 6,310 | $7.25 | $45,747.50 |
DisclosureSEC source: 0001231205-20-000105 · edgar.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,586 Underlying: Common Stock · 6,310 shares Expires not disclosed F1 · security: Acquired at a price of $7.25 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018482 · form4.xml · derivative · entry 2 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,477.7007 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:48 UTC | INTEL CORP INTC · Entity 2799 | GrantRestricted Stock Units · Derivative | 3,721 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-016963 · form4.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,721 Underlying: Common Stock · 3,721 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock. F2 · derivative.exercise_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors. F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting. F2 · derivative.expiration_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors. F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:39 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 5,850 | $7.82 | $45,747.00 |
DisclosureSEC source: 0001231205-20-000080 · edgar.xml · derivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,198 Underlying: Common Stock · 5,850 shares Expires not disclosed F1 · security: Acquired at a price of $7.82 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.